Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients.

Mauramo, Matti; Rohde, Luzius; Ramseier, Adrian M; Rovó, Alicia; Waltimo, Tuomas (2017). Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients. Clinical oral investigations, 21(1), pp. 121-126. Springer 10.1007/s00784-016-1760-0

[img] Text
AR_Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (286kB) | Request a copy

OBJECTIVES The aetiology of hyposalivation in haematopoietic stem cell transplantation (HSCT) recipients is not fully understood. This study examined the effects of treatment-related aetiological factors, particularly medications, on stimulated salivary flow in HSCT recipients. SUBJECTS AND METHODS Adult HSCT recipients (N = 118, 66 males, 27 autologous and 91 allogeneic transplants) were examined. Stimulated whole salivary flow rates (SWSFR) were measured before HSCT and at 6 and 12 months post-HSCT. Linear regression models were used to analyse the associations of medications and transplant-related factors with salivary flow rates, which were compared to salivary flow rates of generally healthy controls (N = 247). RESULTS The SWSFR of recipients were lower pre-HSCT (mean ± standard deviation, 0.88 ± 0.56 ml/min; P < 0.001), 6 months post-HSCT (0.84 ± 0.61; P < 0.001) and 12 months post-HSCT (1.08 ± 0.67; P = 0.005) than the SWSFR of controls (1.31 ± 0.65). In addition, hyposalivation (<0.7 ml/min) was more frequent among HSCT recipients pre-HSCT (P < 0.001), 6 months post-HSCT (P < 0.001) and 12 months post-HSCT (P = 0.01) than among controls. The SWSFR was observed to improve over time being significantly higher 12 months post-HSCT compared to pre-HSCT (P < 0.001). The observed decrease of salivary flow could not be explained by the examined transplant-related factors and medications. CONCLUSIONS Decreased stimulated salivary flow rates could not be explained by the examined factors alone; these findings indicate that hyposalivation in HSCT recipients exhibits a multifactorial aetiology. CLINICAL RELEVANCE All HSCT recipients should be considered to be at high risk of hyposalivation and consequent oral diseases, and they should be treated accordingly.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Rovó, Alicia


600 Technology > 610 Medicine & health








Verena Zwahlen

Date Deposited:

29 Mar 2016 10:24

Last Modified:

25 Jan 2018 11:49

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

Drugs; Haematology; Hyposalivation; Medications; Saliva; Stem cell transplantation




Actions (login required)

Edit item Edit item
Provide Feedback